Skip to main content

Table 1 Used adjuvant formulations

From: The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals

Adjuvant

Composition

GLA-LSQ

Liposomes with dioleoylphosphatidylcholine, synthetic TLR-4 agonist glucopyranosyl lipid adjuvant (GLA) and saponin (QS-21)

GLA-SE

Oil-in-water emulsion with squalene, TLR-4 agonist (GLA) and dimyristoyl phosphatidylcholine

GLA-Alum

Aluminum hydroxide with TLR-4 agonist (GLA) and dipalmitoyl phosphatidylcholine

Nanoalum

Aluminum hydroxide nanoparticles with poly(acrylic) acid

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us